BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 1864543)

  • 1. Confirmation of the efficacy of hepatic tissue iron index in differentiating genetic haemochromatosis from alcoholic liver disease complicated by alcoholic haemosiderosis.
    Sallie RW; Reed WD; Shilkin KB
    Gut; 1991 Feb; 32(2):207-10. PubMed ID: 1864543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of hepatic iron measurements in early hemochromatosis and determination of the critical iron level associated with fibrosis.
    Bassett ML; Halliday JW; Powell LW
    Hepatology; 1986; 6(1):24-9. PubMed ID: 3943787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of subjects with abnormal iron studies: role of the hepatic iron index.
    Chapman BA; Horton DM; Burt MJ; Romeril KR; Walmsley TA; Grant SJ; George P
    N Z Med J; 1994 Dec; 107(991):504-7. PubMed ID: 7830980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic stellate cell activation in genetic haemochromatosis. Lobular distribution, effect of increasing hepatic iron and response to phlebotomy.
    Ramm GA; Crawford DH; Powell LW; Walker NI; Fletcher LM; Halliday JW
    J Hepatol; 1997 Mar; 26(3):584-92. PubMed ID: 9075666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between alcoholism and increased hepatic iron stores.
    Irving MG; Halliday JW; Powell LW
    Alcohol Clin Exp Res; 1988 Feb; 12(1):7-13. PubMed ID: 3279862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron storage in relatives of patients with haemochromatosis and in relatives of patients with alcoholic cirrhosis and haemosiderosis. A comparative study of 27 families.
    Powell LW
    Q J Med; 1965 Oct; 34(136):427-42. PubMed ID: 5862745
    [No Abstract]   [Full Text] [Related]  

  • 7. Differential ferrioxamine test in idiopathic haemochromatosis and transfusional haemosiderosis.
    Fielding J; O'Shaughnessy MC; Brunström GM
    J Clin Pathol; 1966 Mar; 19(2):159-64. PubMed ID: 5909697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated serum type IV collagen: a sensitive indicator of the presence of cirrhosis in haemochromatosis.
    George DK; Ramm GA; Walker NI; Powell LW; Crawford DH
    J Hepatol; 1999 Jul; 31(1):47-52. PubMed ID: 10424282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spur cell anaemia and hepatic iron stores in patients with alcoholic liver disease undergoing orthotopic liver transplantation.
    Pascoe A; Kerlin P; Steadman C; Clouston A; Jones D; Powell L; Jazwinska E; Lynch S; Strong R
    Gut; 1999 Aug; 45(2):301-5. PubMed ID: 10403746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythrocyte ferritin content in idiopathic haemochromatosis and alcoholic liver disease with iron overload.
    Van Der Weyden MB; Fong H; Salem HH; Batey RG; Dudley FJ
    Br Med J (Clin Res Ed); 1983 Mar; 286(6367):752-4. PubMed ID: 6402233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The haemochromatosis gene: a co-factor for chronic liver diseases?
    George DK; Powell LW; Losowsky MS
    J Gastroenterol Hepatol; 1999 Aug; 14(8):745-9. PubMed ID: 10482424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnosis of haemochromatosis].
    IJsselstijn L; van Houten AA; Weerkamp F
    Ned Tijdschr Geneeskd; 2017; 161():D1438. PubMed ID: 29145899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of histological and biochemical hepatic iron indexes in the diagnosis of genetic haemochromatosis.
    George PM; Conaghan C; Angus HB; Walmsley TA; Chapman BA
    J Clin Pathol; 1996 Feb; 49(2):159-63. PubMed ID: 8655684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The changing role of liver biopsy in diagnosis and management of haemochromatosis.
    Bassett ML; Hickman PE; Dahlstrom JE
    Pathology; 2011 Aug; 43(5):433-9. PubMed ID: 21716156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum increase and liver overexpression of carbohydrate 19.9 antigen in patients with genetic haemochromatosis.
    Deugnier YM; Rabot AF; Guyader D; Moirand R; Turlin B; Boucher E; Lebert P; Brissot P
    Gut; 1994 Aug; 35(8):1107-11. PubMed ID: 7926915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver fibrosis in genetic hemochromatosis. Respective roles of iron and non-iron-related factors in 127 homozygous patients.
    Loréal O; Deugnier Y; Moirand R; Lauvin L; Guyader D; Jouanolle H; Turlin B; Lescoat G; Brissot P
    J Hepatol; 1992 Sep; 16(1-2):122-7. PubMed ID: 1484146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disrupted hepcidin regulation in HFE-associated haemochromatosis and the liver as a regulator of body iron homoeostasis.
    Bridle KR; Frazer DM; Wilkins SJ; Dixon JL; Purdie DM; Crawford DH; Subramaniam VN; Powell LW; Anderson GJ; Ramm GA
    Lancet; 2003 Feb; 361(9358):669-73. PubMed ID: 12606179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of alcoholism in hepatic iron storage disease.
    Powell LW
    Ann N Y Acad Sci; 1975 Apr; 252():124-34. PubMed ID: 1056721
    [No Abstract]   [Full Text] [Related]  

  • 19. Current concepts in rational therapy for haemochromatosis.
    Crawford DH; Halliday JW
    Drugs; 1991 Jun; 41(6):875-82. PubMed ID: 1715264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential ferrioxamine test in haemochromatosis and liver diseases.
    Barry M; Cartei G; Sherlock S
    Gut; 1969 Sep; 10(9):697-704. PubMed ID: 5386626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.